AbbVie Inc. (ABBV)
AbbVie Inc is an American multinational biopharmaceutical company based in North Chicago, Illinois. It was created in 2013 as a spin-off of Abbott Laboratories. AbbVie is focused on developing and marketing advanced therapies for severe and chronic conditions, emphasizing oncology, immunology, and virology.
Company Info
| ISIN | US00287Y1091 |
|---|---|
| CUSIP | 00287Y109 |
| Sector | Healthcare |
| Industry | Drug Manufacturers—General |
Highlights
| Market Cap | $251.40B |
|---|---|
| EPS | $3.65 |
| PE Ratio | 39.01 |
| PEG Ratio | 1.28 |
| Revenue (TTM) | $55.14B |
| Gross Profit (TTM) | $41.53B |
| EBITDA (TTM) | $27.99B |
| Year Range | $128.24 - $162.75 |
| Target Price | $154.21 |
| Short % | 0.63% |
| Short Ratio | 1.90 |
Share Price Chart
Loading data...
Performance
The chart shows the growth of an initial investment of $10,000 in AbbVie Inc., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.
Compare to other instruments
Popular comparisons: ABBV vs. ABT, ABBV vs. PFE, ABBV vs. MSFT, ABBV vs. JNJ, ABBV vs. SCHD, ABBV vs. PEP, ABBV vs. ADI, ABBV vs. WMT, ABBV vs. EPD, ABBV vs. LSI
Return
AbbVie Inc. had a return of -7.68% year-to-date (YTD) and -7.69% in the last 12 months. Over the past 10 years, AbbVie Inc. had an annualized return of 15.79%, outperforming the S&P 500 benchmark which had an annualized return of 9.87%.
| Period | Return | Benchmark |
|---|---|---|
| Year-To-Date | -7.68% | 19.67% |
| 1 month | 0.66% | 8.42% |
| 6 months | 7.00% | 7.29% |
| 1 year | -7.69% | 12.71% |
| 5 years (annualized) | 13.98% | 10.75% |
| 10 years (annualized) | 15.79% | 9.87% |
Monthly Returns Heatmap
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023 | -8.71% | -2.34% | 12.25% | -1.75% | 1.43% | -4.34% | 0.86% |
Risk-Adjusted Performance
This table presents a comparison of risk-adjusted performance metrics for AbbVie Inc. (ABBV) and S&P 500 (^GSPC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| Sharpe ratio | Sortino ratio | Omega ratio | Calmar ratio | Ulcer Index | |
|---|---|---|---|---|---|
ABBV AbbVie Inc. | -0.38 | ||||
^GSPC S&P 500 | 0.91 |
Dividend History
AbbVie Inc. granted a 4.13% dividend yield in the last twelve months. The annual payout for that period amounted to $5.92 per share.
| Period | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend | $5.92 | $5.64 | $5.20 | $4.72 | $4.28 | $3.59 | $2.56 | $2.28 | $2.02 | $1.66 | $1.60 |
Dividend yield | 4.13% | 3.49% | 3.84% | 4.41% | 4.83% | 3.89% | 2.65% | 3.64% | 3.41% | 2.54% | 3.03% |
Monthly Dividends
The table displays the monthly dividend distributions for AbbVie Inc.. The dividends shown in the table have been adjusted to account for any splits that may have occurred.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023 | $1.48 | $0.00 | $0.00 | $1.48 | $0.00 | $0.00 | $1.48 | $0.00 | $0.00 | $1.48 | $0.00 | |
| 2022 | $1.41 | $0.00 | $0.00 | $1.41 | $0.00 | $0.00 | $1.41 | $0.00 | $0.00 | $1.41 | $0.00 | $0.00 |
| 2021 | $1.30 | $0.00 | $0.00 | $1.30 | $0.00 | $0.00 | $1.30 | $0.00 | $0.00 | $1.30 | $0.00 | $0.00 |
| 2020 | $1.18 | $0.00 | $0.00 | $1.18 | $0.00 | $0.00 | $1.18 | $0.00 | $0.00 | $1.18 | $0.00 | $0.00 |
| 2019 | $1.07 | $0.00 | $0.00 | $1.07 | $0.00 | $0.00 | $1.07 | $0.00 | $0.00 | $1.07 | $0.00 | $0.00 |
| 2018 | $0.71 | $0.00 | $0.00 | $0.96 | $0.00 | $0.00 | $0.96 | $0.00 | $0.00 | $0.96 | $0.00 | $0.00 |
| 2017 | $0.64 | $0.00 | $0.00 | $0.64 | $0.00 | $0.00 | $0.64 | $0.00 | $0.00 | $0.64 | $0.00 | $0.00 |
| 2016 | $0.57 | $0.00 | $0.00 | $0.57 | $0.00 | $0.00 | $0.57 | $0.00 | $0.00 | $0.57 | $0.00 | $0.00 |
| 2015 | $0.49 | $0.00 | $0.00 | $0.51 | $0.00 | $0.00 | $0.51 | $0.00 | $0.00 | $0.51 | $0.00 | $0.00 |
| 2014 | $0.40 | $0.00 | $0.00 | $0.42 | $0.00 | $0.00 | $0.42 | $0.00 | $0.00 | $0.42 | $0.00 | $0.00 |
| 2013 | $0.40 | $0.00 | $0.00 | $0.40 | $0.00 | $0.00 | $0.40 | $0.00 | $0.00 | $0.40 | $0.00 | $0.00 |
Dividend Yield & Payout
Dividend Yield
Payout Ratio
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way.
Worst Drawdowns
The table below displays the maximum drawdowns of the AbbVie Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the AbbVie Inc. was 45.09%, occurring on Aug 15, 2019. Recovery took 330 trading sessions.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -45.09% | Jan 29, 2018 | 390 | Aug 15, 2019 | 330 | Dec 4, 2020 | 720 |
| -31.61% | Jul 29, 2015 | 61 | Oct 22, 2015 | 383 | May 2, 2017 | 444 |
| -21.92% | Apr 11, 2022 | 120 | Sep 30, 2022 | — | — | — |
| -19.82% | Dec 8, 2014 | 43 | Feb 9, 2015 | 90 | Jun 18, 2015 | 133 |
| -13.11% | Dec 19, 2013 | 25 | Jan 27, 2014 | 78 | May 19, 2014 | 103 |
Volatility Chart
The current AbbVie Inc. volatility is 4.70%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.